Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of ALK Grass Tablet in seasonal grass pollen-induced rhinoconjunctivitis
2004-000083-27Phase 3Completed
- Sponsor
- ALK-Abelló
- Start
- Jul 2004
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in allergic rhinoconjunctivitis (ARC) comparing ALK Grass Tablet Phleum pratense with Placebo (2 arms). Primary endpoints: Average rhinoconjunctivitis symptom score and Average rhinoconjunctivitis medication score. Started Jul 2004; status: completed.
02
Drugs
phleum pratense allergen extract
03
Conditions
allergic rhinoconjunctivitis (ARC)
Beyond the preview
Go deeper on 2004-000083-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000083-27.